The Journal of thoracic and cardiovascular surgery
-
J. Thorac. Cardiovasc. Surg. · Nov 2024
Revascularization after Minimally Invasive Coronary Artery Bypass Grafting in 566 Patients: Is It a Problem?
Minimally invasive coronary artery bypass grafting (MICS CABG) allows visualization and revascularization of all myocardial territories through a small anterolateral thoracotomy, with or without cardiopulmonary bypass. It is increasing in popularity as a safe and effective alternative to sternotomy CABG. In this study, we examined the correlates and long-term outcomes of repeat revascularization (RR) in patients who undergo MICS CABG. ⋯ Among 566 patients who underwent MICS CABG over a 17-year period, RR was an infrequent event affecting 8.7% of patients, with no negative impact on long-term survival.
-
J. Thorac. Cardiovasc. Surg. · Nov 2024
A Multicenter Analysis of Aortic Root Replacement: Non-Native Chest Increases Risk of Post-Operative Mortality.
Re-do root replacement poses a significant technical challenge, increasing the potential risk of morbidity and mortality. This multi-institution study compared the outcomes of aortic root replacement stratified by chest surgery and aortic root history. ⋯ Patients undergoing root replacement in a non-native chest have a significant risk of morbidity and mortality. However, prior root and true re-do root replacement do not appear to add additional risk, with primary risk contributed by operating in a prior surgical field.
-
J. Thorac. Cardiovasc. Surg. · Nov 2024
Outcomes after hospital discharge in children requiring post-cardiotomy extracorporeal membrane oxygenation: a binational retrospective cohort study.
To describe longer-term survival and morbidity outcomes after hospital discharge in a binational cohort of children who required extracorporeal membrane oxygenation after cardiac surgery. ⋯ In total, 38% of children who required ECMO after cardiac surgery did not survive beyond 1 year. However, of patients who survived to hospital discharge, 95% were alive at 1 year. Approximately 80% of patients were alive at 5 years after hospital discharge. Outcomes were poorer in patients with single-ventricle physiology. In total, 40% of patients had significant morbidity after hospital discharge.
-
J. Thorac. Cardiovasc. Surg. · Nov 2024
Esophagectomy may have a role in stage IV esophageal adenocarcinoma.
We sought to determine whether aggressive local treatment provides a benefit in patients with stage IV esophageal adenocarcinoma and to determine factors associated with survival. ⋯ Aggressive local treatment may provide a benefit for highly selected patients with advanced or metastatic esophageal adenocarcinoma.